Increased of αAPP-immunoreactive neurones in the entorhinal cortex after head injury

NeuroReport

Volumn 6, Issue 1, 1994, Pages 161-164

  McKenzie, Jeanette E ^a   Gentleman, Stephen M ^a   Roberts, Gareth W ^b   Graham, David I ^c   Royston, M Claire ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer s disease; Amyloid; Anatomy; Head injury; Temporal cortex; APP; Pathology

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD INJURY; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; TEMPORAL CORTEX;

ADOLESCENT; ADULT; AGED; AMYLOID BETA-PROTEIN PRECURSOR; CELL COUNT; COMPARATIVE STUDY; CRANIOCEREBRAL TRAUMA; ENTORHINAL CORTEX; FEMALE; HUMAN; MALE; MIDDLE AGE; NEURONS; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T;

EID: 0028670780     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/00001756-199412300-00041     Document Type: Article

References (24)

1. Roberts GW, Leigh PN and Weinberger D. Neuropsychiatric Disorders. London: Wolfe Medical Publishers, 1993.
2. Hardy J. Trends Neurosci 15, 200-201 (1992).
3. Selkoe DJ. J Neuropathol Exp Neurol 53, 438-447 (1994).
4. Royston MC, Rothwell NJ and Roberts GW. Trends Pharmacol Sci 13, 131-133 (1992).
5. McGeer PL and Rogers J. Neurology 42, 447-449 (1992).
6. Griffin WST, Sheng JG, Gentleman SM etal. Neurosci Lett 176, 133-136 (1994).
7. Braak H and Braak E. Acta Neuropathol 82, 239-259 (1991).
8. Roberts GW, Nash M, Ince PG et al. NeuroReport 4, 7-9 (1993).
9. Roses AD, Strittmatter WJ, Pericak-Vance MA et al. Lancet 343, 1564-1565 (1994).
10. Mortimer JA, van Duijn CM, Chandra V etal. IntJ Epidemiol 20(S2), 528(1991).
11. Mayeux R, Maestre G, Ottman R etal. NeurobiolAgeing 15 (Suppl 1) S73: 300
12. Gentleman SM, Graham Dl and Roberts GW. Molecular pathology of head trauma: altered /3APP metabolism and the aetiology of Alzheimer's disease. In: Kogure K, HossmanKand SiesjoBK, eds. The Neurobiology of Ischaemic Brain Damage, Progress in Brain Research, Vol 96. Amsterdam: Elsevier, 1993; 237-246.
13. Roberts GW, Gentleman SM, Lynch A etal. J Neurol Neurosurg Psychiatry 57, 419-425(1994).
14. McKenzie JE, Gentleman SM, Roberts GW et al. Neurodegeneration. In press
15. Royston MC, Roberts GW and Rothwell NJ. Trends Pharmacol Sci 13, 131-133 (1992).
16. -Abe K, Tanzi RE and Kogure K. Neurosci Lett 125, 172-174 (1991).
17. Pluta R, Kida E, Lossinsky AS et al. Brain Res 649, 323-328 (1994).
18. Tomimoto H, Wakita H, Akiguchi I et al. Cerebral Blood Flow Metab 14, 565-573 (1994).
19. Roberts GW, Gentleman SM, Lynch A etal. Lancet 338, 1422-1423 (1991).
20. Lishman WA. Organic Psychiatry 2nd ed. London: Blackwell, 1987: 137-186.
21. Kotapka MJ, Gennarelli TA, Graham Dl et al. J Neurotrauma 8, 247-258 (1991).
22. Kotapka MJ, Graham Dl and Gennarelli TA. Acta Neuropathol 83, 530-534 (1992).
23. Van Hoesen GW, Hyman BT and Damasio AR. Hippocampus 1, 1-8 (1991).
24. Masliah E, Mallory M, Hansen L et al. Neurosci Lett 174, 67-72 (1994).